- $99.29m
- -$120.71m
- $19.09m
Brief: Graphite Bio Posts Q3 Loss Per Share Of $0.28
Graphite Bio Inc reports results for the quarter ended in June - Earnings Summary
Brief: Graphite Bio Reports Q2 2021 Financial Results
U.S. STOCKS ON THE MOVE-Philip Morris, HCA Healthcare, Neurobo Pharma, PPG Industries
U.S. STOCKS ON THE MOVE-Philip Morris, PPG Industries, NeuroMetrix, Immunome
Gene editing firm Graphite Bio rises as analysts say "buy"
Intellia continues rally after big equity raise upsize, boosts peers
Newly listed Verve Therapeutics, Graphite Bio jump on Intellia breakthrough
Brief: Graphite Bio Shares Open 30% Above IPO Price In Nasdaq Debut
NASDAQ RESUMED AT 12:00 PM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 04:00 AM
Brief: Graphite Bio Announces Pricing Of Upsized Initial Public Offering
NASDAQ TRADE HALT REASON NOT AVAILABLE AT 04:01 AM
Live Markets: Chock full of IPOs
Brief: Graphite Bio Inc Sees IPO Of Up To 12.5 Million Shares Of Common Stock Priced To Be Between $15 And $17 Per Share